trending Market Intelligence /marketintelligence/en/news-insights/trending/whutpzd9qsctjkuw7ktu3w2 content esgSubNav
In This List

Catalyst Biosciences closes $115M common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Catalyst Biosciences closes $115M common stock offering

Catalyst Biosciences Inc. closed its underwritten public offering of 3,382,352 common shares at $34 apiece with gross proceeds of about $115 million.

The shares include the full exercise of the underwriters' option to buy an additional 441,176 shares.

JonesTrading Institutional Services LLC acted as sole book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book runner.

LifeSci Capital LLC acted as lead manager and B. Riley FBR Inc. acted as co-manager of the offering.